301267.SZ
华厦眼科
SZSE · Q 卫生 · CN
CNY 15.82
−1.37%Year over year
Reported trailing growth
- Revenue
- +1.3%
- EBITDA
- —
- EBIT
- +1.4%
- EPS
- +8.7%
- Free cash flow
- +20.5%
- Operating cash flow
- +8.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +8.6%
- EBITDA
- -2.6%
- EBIT
- -5.4%
- Net income
- -5.0%
- EPS
- -7.5%
- Free cash flow
- +5.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026